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T 
HE multistep theory of tumorigenesis is now widely 
accepted. During the tumor development the genetic 
alterations are accumulated, oncogenes are activated, 
and tumor suppressor genes are inactivated. Recently, the in- 
teresting idea is emerging that some cell adhesion molecules, 
integral membrane proteins, may work as tumor suppressors 
(Hedrick et al.,  1993).  Most of these cell adhesion mole- 
cules are known to be intimately associated with cytoskeletal 
proteins underlying plasma membranes (peripheral  mem- 
brane  proteins)  to  form a  specialized membrane domain 
called a junctional apparatus including tight junctions (TJ) ~, 
adherens junctions (AJ),  and desmosomes (DS)  (Fig.  1). 
These  peripheral  membrane  proteins  concentrated  in  a 
"plaque" are thought to play a  role in signal transduction 
from adhesion receptors (Juliano and Haskill, 1993) and in 
the regulation of adhesion molecules (Takeichi,  1991). Re- 
cently, the application of gene engineering techniques to 
plaque proteins has generated a wealth of novel observations, 
leading to the speculation that some of these proteins are re- 
quired to suppress the development of tumors, i.e., act as a 
kind of "tumor suppressors" Here we review these findings 
and discuss some functions of the plaque proteins in normal 
cells as well as in tumorigenesis. 
Tumor Suppressor Genes 
The definition of'tumor suppressor gene" is not clear at pres- 
ent. Originally, the existence of tumor suppressor genes was 
suggested by the genetic studies of tumor formation and sup- 
pression in platyfish-swordtail hybrids (Anders,  1967) and 
in Drosophila (Gateff and Schneiderman, 1974). Fusion ex- 
periments between normal and tumor cells provided a way 
to analyze mammalian tumor suppressor genes: normal tu- 
mor cell hybrids often display a nonmalignant phenotype, 
suggesting that "tumor suppressors" derived from the ge- 
nome of a normal cell normalize the growth patterns of their 
malignant partners  (Harris,  1988).  Along this line,  some 
genes were recently identified as "tumor suppressor genes" 
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due to the fact that expression of their products in trans- 
formed cells resulted in the suppression of the malignant 
phenotype, i.e., a reduced ability to grow in soft agar,  sup- 
pression of the development of tumors in vivo. 
Another method for the identification of tumor suppressor 
genes  is  to  identify the  chromosomal gene  locus  whose 
defects cause various types of human familial tumors, and to 
isolate these genes by molecular cloning. For the chromo- 
some assignment, specific losses of heterozygosity (LOH) in 
tumors are often analyzed. Usually in this case, it is not clear 
what  types  of  malignant  phenotypes  (overproliferation, 
transformation, dedifferentiation, invasion,  or metastasis) 
the alterations of these genes are responsible for, but these 
genes are called "tumor suppressor genes: 
In this mini-review, we use the word "tumor suppressor" 
in an extended sense.  The tumor suppressors are tentatively 
defined here as proteins which suppress one or several malig- 
nant  phenotype  criteria  of  tumor  formation,  including 
dedifferentiation, invasion, and metastasis. 
Tight Junctions 
The TJ is an element of epithelial and endothelial junctional 
complexes (Fig. 1). In polar epithelial cells, it seals the cells 
together at a subapical position and creates the primary bar- 
rier to the diffusion of solutes in the paracellular pathway. 
It  also  works  as  a  boundary  between  the  apical  and 
basolateral plasma membrane domains to create cell polar- 
ization (Gumbiner, 1987; Stevenson et al., 1988).  The mo- 
lecular organization of TJ is poorly understood; presently, 
there is no information on the integral membrane proteins 
of TJ, especially adhesion molecules. So far, by mAb pro- 
duction, Z0-1 (220 kD), cingulin (140 kD), 7H6 (155 kD), 
and Z0-2 (160 kD) were reported as undercoat-constitutive 
proteins localized at TJ (Citi, 1993). Among cDNAs encod- 
ing these proteins, only the Z0-1 eDNA has been isolated and 
completely sequenced (Itoh et al., 1991, 1993; see "Note"). 
Although it was not mentioned in the original paper of  Itoh 
et al. (1993),  close comparison of the amino acid Z0-1 se- 
quence with the sequences of other proteins revealed that the 
amino-terminal  half  of  this  protein  displays  significant 
similarity to the product of the lethal(1)discs  large-l(dlg) 
gene in Drosophila (Fig. 2; see "Note"). In Drosophila, so 
far seven tumor suppressor genes have been identified by 
isolating recessive lethal mutations in which cell prolifera- 
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junctional  complex consists of the tight junction  (TJ), adherens 
junction (A  J), and desmosome (DS). Adherens junctions and des- 
mosomes are characterized by a well developed plasmalemmal un- 
dercoat, i.e., the plaque structure. (MV) microvilli; (*) intercellular 
space. Bar, 0.1 /zm. 
tion  in  imaginal  discs  continue beyond the normal  limits 
(Gateff  and Mechler, 1989). Sequence analysis of the cDNA 
of dig, one of the Drosophila tumor suppressor genes, re- 
veals that its product contains some putative functional do- 
mains:  a  filamentous  domain,  an  SH3  domain,  and  the 
guanylate kinase  domain  (Woods  and  Bryant,  1991).  As 
shown in Fig.  2,  four regions are conserved between the 
amino-terminal half of Z0-1 and the dig gene product, and 
three of them are included in the filamentous and guanylate 
kinase domains of the dig gene product.  Interestingly, in 
Drosophila  epithelial  cells,  the dig gene product was  re- 
ported to be localized in the undercoat of the septate junc- 
tions (Woods and Bryant,  1991),  which are thought to be 
the counterpart of the vertebrate TJ (Noriot-Timothee and 
Noriot,  1980). 
From the above we speculate that Z0-1 can act as a tumor 
suppressor in vertebrate cells.  This speculation, of course 
must be evaluated by further functional analysis of Z0-1. Fur- 
thermore, the structure and function of the other components 
of TJ should be analyzed to clarify the relationship between 
TJ and tumorigenesis. 
Adherens Junctions 
The AJ represent a specialized class of cell-to-cell and cell- 
to-substrate associations: the major adhesion molecules are 
cadherins and integrins, respectively (Geiger, 1983; Geiger 
et al.,  1985; Hynes, 1987; Burridge et al.,  1988; Takeichi, 
1991) (see Fig.  1). This type of  junction is characterized by 
a well-developed undercoat (plaque) on the cytoplasmic sur- 
face of the junctional membrane with which bundles of actin 
filaments are tightly associated. Since AJ are commonly be- 
lieved to be directly involved in tissue morphogenesis, the 
molecular architecture of the plaque of both cell-to-cell and 
cell-to-substrate AJ has attracted interest (Burridge et al., 
1988; Tsukita et al.,  1992). 
The first protein reported to be concentrated at AJ was 
c~-actinin (Lazarides and Burridge, 1975). This protein with 
a  molecular mass  of 100 kD  is  an abundant cytoplasmic 
actin-binding protein and found along microfilaments and in 
the plaque of both cell-to-cell and cell-to-substrate AJ. The 
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Figure 2. Comparison of mouse ZO-1 
with Drosophila dig gene product. (A) 
Schematic structures of mouse ZO-I 
and Drosophila dig gene product. The 
dig gene product contains three puta- 
tive functional domains;  filamentous 
domain,  SH3 domain, and guanylate 
kinase  domain.  Boundaries  of each 
domain are shown by the number of 
boundary residues. Four regions (a-d) 
are conserved between the amino-ter- 
minal half of ZO-1 and the dig gene 
product. Respective  regions correspond 
to amino acids 12-144,409-510,  613- 
667, 701-801 in  ZO-I  and to amino 
acids 29-163, 472-573, 743-793, 859- 
955 in the dig gene product. The SH3 
domain in dig shows 38% identity to 
that in crk, whereas the corresponding 
region in mouse ZO-1 is not so similar 
to the crk SH3 (28%), restraining us 
from concluding that mouse ZO-1 in- 
cludes an SH3 domain. (B) Compari- 
son of amino acid sequences between mouse ZO-1 (upper sequence) and Drosophila dig gene product (lower sequence). The amino acid 
sequences of the four homologous domains (a-d) are aligned. Asterisks and dots denote identity and homology, respectively, and dashes 
indicate gaps introduced to optimize the alignment. The sequences were initially aligned by means of the MAXMH computer program. 
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which is associated with the plaques of both cell-to-cell and 
cell-to-substrate AJ  (Geiger,  1979).  The complete amino 
acid sequences of these proteins have been determined by 
eDNA cloning (Arimura et al.,  1988;  Baron et al.,  1987; 
Coutu and Craig,  1988;  Price et al.,  1989).  Using these 
cDNAs, in cell transfection experiments Ben-Zc'ev's  group 
has shown that both c~-actinin and vinculin have a suppres- 
sive effect on the transformed phenotype (Gltick et al., 1993; 
Rodriguez Fermtndez et al.,  1992).  In their experiments, 
human ct-actinin eDNA was transfected into highly malig- 
nant SV-40-transformed mouse fibroblasts expressing six- 
fold lower levels of endogenous t~-actinin,  and chicken vin- 
culin cDNA was introduced into two mouse tumor cell lines 
expressing diminished levels  of the endogenous vinculin. 
Restoration of o~-actinin  and vinculin in these cells, up to the 
level of normal cells, resulted in an apparent increase in sub- 
strate adhesiveness, a decrease in the ability to grow in soft 
agar, and suppression of tumor development and metastases 
after injection into syngeneic hosts  or nude mice.  These 
findings indicate that a-actinin and vinculin can act as tumor 
suppressors, at least in the experimental mouse system. 
Radixin is a barbed end-capping, actin-modulating  protein 
first identified as one of the major plaque proteins isolated 
from cell-to-cell AJ in rat liver (Tsukita et al.,  1989).  Se- 
quence  analysis of the  radixin  eDNA  demonstrated that 
radixin is highly homologous to ezrin and moesin, pointing 
to the existence of th~ ezrin-radixin-moesin (ERM) family 
(Funayama et al.,  1991; Sato et al.,  1992).  Ezrin was first 
identified as one of the components of intestinal microvilli 
(Bretscher, 1983; Gould et al., 1989; Turunen et al., 1989), 
and moesin originally thought to be an extracellular protein, 
was later found to be an intracellular protein (Lankes and 
Furthmayr, 1991). As shown in Fig. 3, among the ERM fam- 
ily members, amino acid substitutions in the amino-terminal 
half of each  member  are  highly  conservative:  showing 
~83 % identity in the amino-terminal half and *65 % in the 
carboxy-terminal half. The amino-terminal half domain also 
shows some similarity to the amino-terminal half  of the band 
4.1  protein,  one of the  undercoat-constituent proteins  of 
erythrocyte membranes.  Recent detailed immunolocaliza- 
tion has also clarified that ERM family  members are concen- 
trated at the plaque of the cell-to-ceU  and cell-to-substrate 
AJ, at cleavage furrows, microviUi,  and ruffling membranes 
(Sato et al.,  1992).  The most prominent feature shared by 
these sites is the tight and dense association of  actin filaments 
with plasma membranes, leading us to conclude that ERM 
family  members  play  a  crucial  role  in  the  actin  fila- 
ment/plasma  membrane  association  in  general.  Surpris- 
ingly, these ERM family members were recently found to 
have a close relationship to the tumor suppressor protein of 
neurofibromatosis 2  (NF2),  one of the two major human 
genetic disorders both of which display autosomal dominant 
inheritance  and  involve  tumors  of  the  nervous  system 
(Trofatter et al., 1993; Rouleau et al., 1993). Genetic linkage 
studies of NF2 had revealed that this familial tumor is caused 
by inactivation of a tumor suppressor gene in chromosome 
22q12 (Rouleau et al.,  1987),  and recently, a candidate for 
the NF2 tumor suppressor gene was cloned. The candidate 
gene was shown to encode a cytoplasmic protein with a strik- 
ing similarity to  ERM  family members,  and was named 
"merlin" (moesin-ezrin-radixin-like protein) or "schwanno- 
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Figure 3. ERM family and merlin. The structures of mouse ezrin, 
mouse radixin, mouse moesin, human merlin, and human band 4.1 
protein are compared. These proteins have a homologous domain 
([]) in their amino-terminal half. The identity of the amino-termi- 
nal and carboxyl-terminal  halves of  each protein with those of  ezrin 
was calculated and shown in each box. 
min:  Clusters of amino acids identical in merlin and the 
ERM family is concentrated in the amino-terminal half of 
each molecule (,x,62%  identity) (Fig.  3).  Therefore, it is 
tempting to speculate that merlin, and probably other ERM 
family members, act as tumor suppressors by affecting the 
actin filament/plasma membrane association. 
Three  cytoplasmic  proteins  were  reported  to  be  co- 
precipitated with cadherin molecules in immunoprecipita- 
tion experiments with anti-cadherin antibodies (Ozawa  et 
al.,  1989;  Vestweber  and Kemler,  1984;  Peyrieras et al., 
1985): ot-(102 kD), B-(88 kD) and 3/-(80 kD) catenin. Dele- 
tion and mutagenesis experiments with cadherin molecules 
clearly revealed that cadherin molecules lacking the catenin 
binding sites cannot bind to the cytoskeleton or connect cells 
to each other (Nagafuchi and Takeichi, 1988; Ozawa et al., 
1989). 
Recently, orcatenin eDNA was isolated and its deduced 
amino acid sequence revealed that ot-catenin resembles vin- 
culin (Nagafuchi et al.,  1991; Herrenknecht et al.,  1991). 
Using a mAb called ot-18 which clearly recognizes human 
a-catenin (Nagafuchi, A., and Sh. Tsukita, manuscript sub- 
mitted for publication), Hirohashi's group has examined the 
expression level  of ot-catenin  in a human lung cancer cell 
line, PC9. PC9 cells had been known to strongly express nor- 
mal E-cadherin molecules on their cell surface, but to show 
reduced cadherin-mediated aggregation activity, resulting in 
poorly differentiated round-shaped ceils. Immunoprecipita- 
tion, immunoblot and PCR analyses have shown that PC9 
cells lacked the expression of intact tx-catenin due to the ho- 
mologous deletion of its gene (Shimoyama et al., 1992; Oda 
et al., 1993). Furthermore, transfection of the eDNA encod- 
ing c~-catenin into PC9 cells brought about a drastic restora- 
tion of cell aggregation activity, resulting in cultures of a 
well-differentiated  epithelial cell (Hirano et al., 1992). Most 
recently, using mAb ot18, the loss of a-catenln expression 
was also observed in a human prostate cancer cell line, PC3, 
which shows a high expression level of E-cadherin but lacks 
cell-cell adhesion ability (Morton et al.,  1993).  Therefore, 
we are led to conclude that, at least in PC9 and PC3 cells, 
wcatenln is a  key protein not only to exert the cadherin- 
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tion  phenomena.  The  expression  of ot-catenin  in  human 
adenocarcinomas was then examined, especially those of the 
scirrhous-type,  in which cancer cells are characteristically 
detached from each other to form single cells that infiltrate 
the connective tissue in a scattered manner  (Ochiai et al., 
1994; Kadowaki et al.,  1994). These scattered cancer cells 
were reported occasionally to express E-cadherin at a nor- 
mal level, leading us to speculate that, like PC9 cells, these 
scattered cancer cells also lack ot-catenin. 
The scirrhous-type adenocarcinomas  with scattered cell 
growth are most commonly found in the stomach and the 
breast.  Interestingly,  close immunohistochemical  analysis 
showed apparently complete loss of tx-catenin  expression in 
gastric and breast scirrhous adenocarcinomas in •55  % and 
~75 % of the cases studied, respectively. Most recently, the 
human  et-catenin gene was assigned to chromosome 5q21 
and/or 31, for which a LOH had frequently been reported 
(Furukawa et al.,  1993; Morton, R. A., C. M. Ewing, J. J. 
Wasmuth, J. D.  McPherson, J. Overhauser,  A.  Nagafuchi, 
Sh. Tsukita, and W. B. Isaacs, manuscript submitted for pub- 
lication):  the  APC  gene,  a  tumor  suppressor  gene in the 
familial adenomatous polyposis, is also located in this chro- 
mosome region (Kinzler et al.,  1991). And all these findings 
lead us to suggest that the loss of ot-catenin may be a key step 
for the scattered phenotype of the scirrhous-type adenocarci- 
nomas, i.e., that ot-catenin is a suppressor of tumor cell inva- 
sion as well as of cell dedifferentiation. Therefore, ovcatenin 
is a good candidate for the "suppressor" in scirrhous-type ad- 
enocarcinoma with scattered cell growth. 
Desmosomes 
The DS, another cell-to-cell junctional apparatus, is charac- 
terized by a prominent plaque, through which intermediate- 
sized filaments are tightly and densely associated with the 
plasma  membrane  (see  Fig.  D.  The  adhesion  molecules 
working  in  DS  are  called  desmogleins  and  desmocolins, 
which belong to the cadherin superfamily (Koch et al., 1990; 
Buxton et al.,  1993). Since DS can be isolated from bovine 
muzzle epidermis,  most of the major plaque proteins have 
already been identified (Schwarz et al.,  1990) and cDNAs 
encoding some plaque proteins such as desmoplakin I & II, 
plakoglobin etc., have been sequenced (Green et al.,  1988, 
1990; Franke et al., 1989). So far, only one plaque protein, 
desmoyokin, was suggested to have something to do with the 
tumor suppression, but this relationship remains to be fur- 
ther evaluated in detail (Hieda et al., 1989; Hashimoto et al., 
1993). 
Conclusions 
The  results  discussed above favor the idea that junctional 
plaque  proteins  play  a  crucial  role  in  suppression  of the 
malignant phenotypes of tumors such as overproliferation, 
transformation,  dedifferentiation,  invasion, and metastasis. 
Recently,  some proto-oncogenic  tyrosine  kinases  such  as 
c-yes and c-src kinases were found to be concentrated at the 
cadherin-based  AJ  plaque  (Tsukita  et  al.,  1991),  and  a 
unique tyrosine kinase called FAK to be involved in the sig- 
nal transduction in the integrin-based AJ plaque (Juliano and 
Haskill,  1993).  Therefore,  the junctional  plaque  structure 
appears  to have an intimate  relationship  with both tumor 
suppressor gene and oncogene products. 
The question is then how junctional plaque proteins are in- 
volved in the  suppression  of the malignant  phenotypes of 
tumors.  As to the  overproliferation,  two explanations  are 
possible. The first explanation is that the major task of junc- 
tional plaque proteins is to bring together adhesion receptors 
and signal-transducers involved in the negative regulation of 
cell growth at a specialized membrane domain (junctional 
apparatus).  This mechanism is expected to drastically up- 
regulate the efficiency of the signal transduction.  Alterna- 
tively, the junctional plaque protein itself may act as a signal 
transducer to transmit the information from adhesion recep- 
tors  to  the  cell's  interior,  although  at  present  how  these 
cytoskeletal proteins underlying the plasma membrane are 
directly involved in the signal transduction system remains 
unknown. As to the other malignant phenotypes, the expla- 
nation may be simple: the junctional plaque proteins may be 
directly  involved in  the  regulation  of the  organization  of 
cytoskeletons, cell adhesion,  and cell motility. 
In future, genetic and biochemical experiments with Dro- 
sophila tumor suppressor genes will shed light on this field. 
In  this  connection,  interestingly,  the  lethal  giant  larvae 
(112]gl) protein,  one of the Drosophila tumor  suppressor 
genes, was recently reported to be localized at the undercoat 
of the  cell-to-cell  adhesion  sites,  just  like  dig  products 
(T6r6k et al., 1993). The technique of gene targeting in mice 
will also be powerful in this field. The findings reviewed here 
indicate that in "normal  cells" the submembranous plaque 
proteins play crucial roles in the negative regulation of cell 
growth, the determination of cell shape and differentiation, 
the regulation of cell adhesion and cell motility. If we con- 
tinue to further  investigate  the relationship  between these 
proteins and tumorigenesis,  we may soon be able to under- 
stand the role of the submembranous junctional plaque pro- 
teins in normal cells. 
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Note: Since submission of this mini-review, we received a preprint of the 
article entitled "The tight junction protein Z0-1 is homologous to the Dro- 
sophila discs-large tumor suppressor protein of septate junctions" (Willott, 
E., M. S. Balda, A. S. Fanning, B. Jameson, C. V. Itallie, and J. M. An- 
derson. 1993.  Proc. Natl. Acad.  Sci.  USA.  In press), in which the cDNA 
encoding "human" Z0-1 protein was cloned and sequenced. Comparison 
between this "human" Z0-1 and "mouse" Z0-1 (Ito et al., 1993) reveals that 
they are highly homologous not only within the coding regions (,,090% 
identity) but also in 3'- and 5'-noncoding regions. 
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